← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
Bagai Shaun
Chief Executive Officer | Officer
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001862613
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 3
- Purchases · 24M
- 7
- Average purchase
- $6.9K
- Median purchase
- $7.6K
- Gross purchase value
- $41.5K
Companies: RenovoRx, Inc.
7 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-03-24 | RenovoRx, Inc. | RNXT | Chief Executive Officer | Officer | — | Open filing |
| 2025-12-22 | RenovoRx, Inc. | RNXT | Chief Executive Officer | Officer | $4.5K | Open filing |
| 2025-12-19 | RenovoRx, Inc. | RNXT | Chief Executive Officer | Officer | $4.2K | Open filing |
| 2025-08-26 | RenovoRx, Inc. | RNXT | Chief Executive Officer | Officer | $9.3K | Open filing |
| 2025-04-16 | RenovoRx, Inc. | RNXT | Chief Executive Officer | Officer | $6.8K | Open filing |
| 2025-04-10 | RenovoRx, Inc. | RNXT | Chief Executive Officer | Officer | $8.3K | Open filing |
| 2025-04-08 | RenovoRx, Inc. | RNXT | Chief Executive Officer | Officer | $8.3K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
No completed point-in-time price outcome is available yet.
Research patterns
- First purchase in 12M
- 0/6
- Large purchase ≥ $100k
- 0/6
- Cluster buying · 15D
- 5/7
- Buying the dip
- 0/—
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.